WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark INTRABIO was filed as Word mark on 02/14/2018 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1401943 |
| Register number | 017126384 |
| Countries | 
|
| Base trademark |
No. 017126384,
December 13, 2017
|
| Application date | February 14, 2018 |
| Expiration date | February 14, 2028 |
Trademark owner
Summit House,
170 Finchley Road
GB
170 Finchley Road
GB
Trademark representatives
Dashwood,
69 Old Broad Street
GB
goods and services
05
Pharmaceutical preparations; pharmaceutical preparations for
activating cellular function; pharmaceutical preparations
for the prevention of diseases of the nervous system;
pharmaceutical preparations for treating sensory organ
disorders; pharmaceutical preparations for use in the
prevention and treatment of neurodegenerative diseases;
pharmaceutical preparations for use in the prevention and
treatment of neurodegenerative diseases, namely lysosomal
storage disorders, niemann-pick disease, alzheimer's
disease, parkinson's disease, prion disease, motor neurone
disease, huntington's disease, spinocerebellar ataxia and
spinal muscular atrophy; drugs for medical purposes; drugs
for medical purposes, namely the prevention and treatment of
neurodegenerative diseases; drugs for medical purposes,
namely the prevention and treatment of neurodegenerative
diseases, namely lysosomal storage disorders, niemann-pick
disease, alzheimer's disease, parkinson's disease, prion
disease, motor neurone disease, huntington's disease,
spinocerebellar ataxia and spinal muscular atrophy; reagents
for use in medical genetic testing; diagnostic reagents for
medical laboratory use; diagnostic reagents for medical
laboratory use, namely use in the detection and
identification of neurodegenerative diseases; diagnostic
reagents for medical laboratory use, namely use in the
detection and identification of neurodegenerative diseases,
namely lysosomal storage disorders, niemann-pick disease,
alzheimer's disease, parkinson's disease, prion disease,
motor neurone disease, huntington's disease, spinocerebellar
ataxia and spinal muscular atrophy; amino acid preparations
for medical purposes; amino acid preparations for
pharmaceutical use
42
Scientific and technological services and research and
design relating thereto; industrial analysis and research
services; scientific and technological services and research
in the field of neurodegenerative diseases, namely lysosomal
storage disorders, niemann-pick disease, alzheimer's
disease, parkinson's disease, prion disease, motor neurone
disease, huntington's disease, spinocerebellar ataxia and
spinal muscular atrophy; industrial analysis and research
services related to neurodegenerative diseases, namely
lysosomal storage disorders, niemann-pick disease,
alzheimer's disease, parkinson's disease, prion disease,
motor neurone disease, huntington's disease, spinocerebellar
ataxia and spinal muscular atrophy, design and development
of computer hardware and software related to assays;
clinical trials; conducting clinical trials for
pharmaceutical products; conducting clinical trials for
neurodegenerative diseases, namely lysosomal storage
disorders, niemann-pick disease, alzheimer's disease,
parkinson's disease, prion disease, motor neurone disease,
huntington's disease, spinocerebellar ataxia and spinal
muscular atrophy; medical laboratories for research related
to neurodegenerative diseases, namely lysosomal storage
disorders, niemann-pick disease, alzheimer's disease,
parkinson's disease, prion disease, motor neurone disease,
huntington's disease, spinocerebellar ataxia and spinal
muscular atrophy; providing information about the results of
clinical trials for pharmaceutical products; clinical
research; medical laboratories; research relating to
molecular sciences; medical research; genetic research;
research in the field of gene therapy; biopharmaceutical
research for development of targeted therapies for use in
the treatment of carcinomas and neurodegenerative diseases;
scientific, biochemical, research and development services
in the field of neurodegenerative diseases; providing
scientific information in the field of medical disorders and
their treatment; pharmaceutical drug development services
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 10, 2020 | 2020/3 Gaz | US | Rejection |
| June 14, 2018 | 2018/24 Gaz | US | Rejection |
| February 14, 2018 | 2018/18 Gaz | EM | Registration |
ID: 141401943